Poly Medicure Limited has submitted the Exchange a copy Srutinizers report along with Scrutinizers Report of Annual General Meeting held on September 25, 2025
POLYMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Poly Medicure Limited held its 30th Annual General Meeting on September 25, 2025 via video conferencing, with 86 shareholders attending remotely. All 10 resolutions put to vote were passed with overwhelming shareholder support, including adoption of FY2024-25 financial statements (99.85% in favour) and approval of dividend on equity shares (99.9999% in favour). Notable resolutions included raising the company's borrowing limit from Rs. 400 crore to Rs. 1,000 crore (99.9989% in favour) and the appointment of Shri Pankaj Gupta as a new Whole-time Director designated as Executive Director (98.43% in favour). Three directors — Jugal Kishore Baid, Amit Khosla, and Sonal Mattoo — were re-appointed, along with the cost auditor and a new secretarial auditor for a five-year term from FY2025-26 to FY2029-30. Promoters voted unanimously in favour of every resolution, and overall voting participation stood at 87.45% of outstanding shares.
Shareholders can expect to receive the declared dividend for FY2024-25, while the sharp increase in borrowing capacity (2.5x to Rs. 1,000 Cr) signals upcoming expansion, capex, or acquisition plans. The broad-based approval across all resolutions, including new leadership appointments, reflects strong promoter-investor alignment and stability in corporate governance.